Semi-Annual Consolidated Statement Of Cash Flows

Japan Tissue Engineering Co., Ltd. - Filing #7372755

Concept 2023-04-01 to
2023-09-30
As at
2023-09-30
As at
2023-03-31
2022-04-01 to
2022-09-30
As at
2022-09-30
As at
2022-03-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-9,731,000 JPY
-419,490,000 JPY
Depreciation
67,449,000 JPY
65,593,000 JPY
Interest and dividend income
-389,000 JPY
-576,000 JPY
Increase (decrease) in provision for bonuses
4,246,000 JPY
2,082,000 JPY
Decrease (increase) in trade receivables
187,631,000 JPY
30,317,000 JPY
Decrease (increase) in inventories
40,523,000 JPY
-9,773,000 JPY
Increase (decrease) in trade payables
-78,286,000 JPY
-5,803,000 JPY
Other, net
-35,662,000 JPY
83,584,000 JPY
Subtotal
163,618,000 JPY
-320,838,000 JPY
Interest and dividends received
12,000 JPY
9,000 JPY
Net cash provided by (used in) operating activities
159,964,000 JPY
-324,108,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-40,185,000 JPY
-100,203,000 JPY
Other, net
180,000 JPY
750,000 JPY
Net cash provided by (used in) investing activities
-191,529,000 JPY
-113,420,000 JPY
Cash flows from financing activities
Net cash provided by (used in) financing activities
-133,000 JPY
-401,000 JPY
Net increase (decrease) in cash and cash equivalents
-31,698,000 JPY
-437,930,000 JPY
Cash and cash equivalents
2,002,872,000 JPY
2,034,570,000 JPY
1,095,389,000 JPY
1,533,319,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.